TL;DR: NHS Aquablation now has its south-west centre of excellence at Cheltenham General Hospital, a procedure in which a high-pressure water jet removes excess prostate tissue under ultrasound guidance. Where the jet cuts is proposed by a model trained across 100,000-plus earlier operations, though the surgeon signs off the plan and hundreds of cases have now been completed.

Benign prostatic hyperplasia, the condition treated, reaches upwards of four million English men past the age of 50. Conventional surgery, transurethral resection of the prostate, strips tissue with heat or cutting instruments and carries a longer recovery. Consultant urologist Jeremy Nettleton, who describes the equipment as game-changing for daily throughput, maps the gland on ultrasound before the jet is programmed.

His account of the mechanics is deliberately unglamorous: pressures reach 8,000 psi, but the cut is accurate to within a millimetre and visible on screen throughout. Nettleton cites published outcomes of no new erectile dysfunction, preserved ejaculation in around 90% of patients, and stress incontinence below half a percent — figures that compare with roughly 90% of men seeing ejaculatory change after older techniques.

Andy Ocock, 57, from Cheltenham, wore a catheter for close to a year and had given up running and cycling. His prostate measured well over 100cc, where 80cc already counts as large, and around 80% of that tissue was removed. Two decades of urinary infections brought Ian Kemp, 67, down from north Cornwall; his operation took under an hour and he travelled home the following day.

The AI’s role here is narrower than the headline suggests, and that is the point worth noting for UK health services weighing similar tools. It is planning support constrained by a physical procedure the surgeon controls, with the model’s suggestion reviewable before anything happens. That sits at the opposite end of the risk spectrum from the diagnostic and triage systems drawing regulatory attention elsewhere in the NHS, where an unreviewed output can shape a pathway on its own.

Looking forward: Nettleton hopes more surgeons take up the technique, and Cheltenham is already pulling referrals from across the UK. Whether the centre-of-excellence model spreads will depend less on the technology than on capital budgets and trained operators — the same constraint that has limited every previous surgical robotics rollout in the NHS.